-
1 Comment
Fortive Corporation is currently in a long term uptrend where the price is trading 0.0% above its 200 day moving average.
From a valuation standpoint, the stock is 77.8% cheaper than other stocks from the Technology sector with a price to sales ratio of 5.6.
Fortive Corporation's total revenue sank by 127.6% to $-553M since the same quarter in the previous year.
Its net income has increased by 530.5% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 38.0% to $274M since the same quarter in the previous year.
Based on the above factors, Fortive Corporation gets an overall score of 3/5.
Sector | Technology |
---|---|
Industry | Scientific & Technical Instruments |
ISIN | US34959J1088 |
CurrencyCode | USD |
Exchange | NYSE |
Dividend Yield | 0.4% |
---|---|
Beta | 1.17 |
Target Price | 74.25 |
PE Ratio | 32.0 |
Market Cap | 24B |
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Intelligent Operating Solutions segment provides advanced instrumentation, software and services, which includes electrical test and measurement, facility and asset lifecycle software applications, and worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. Additionally, it markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. Its Precision Technologies segment provides electrical test & measurement, sensing and material technologies under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries. Advanced Healthcare Solutions segment offers critical workflow solutions including instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. The company was incorporated in 2015 and is headquartered in Everett, Washington.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FTV using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024